Page Matthew J, Shamseer Larissa, Altman Douglas G, Tetzlaff Jennifer, Sampson Margaret, Tricco Andrea C, Catalá-López Ferrán, Li Lun, Reid Emma K, Sarkis-Onofre Rafael, Moher David
School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
PLoS Med. 2016 May 24;13(5):e1002028. doi: 10.1371/journal.pmed.1002028. eCollection 2016 May.
Systematic reviews (SRs) can help decision makers interpret the deluge of published biomedical literature. However, a SR may be of limited use if the methods used to conduct the SR are flawed, and reporting of the SR is incomplete. To our knowledge, since 2004 there has been no cross-sectional study of the prevalence, focus, and completeness of reporting of SRs across different specialties. Therefore, the aim of our study was to investigate the epidemiological and reporting characteristics of a more recent cross-section of SRs.
We searched MEDLINE to identify potentially eligible SRs indexed during the month of February 2014. Citations were screened using prespecified eligibility criteria. Epidemiological and reporting characteristics of a random sample of 300 SRs were extracted by one reviewer, with a 10% sample extracted in duplicate. We compared characteristics of Cochrane versus non-Cochrane reviews, and the 2014 sample of SRs versus a 2004 sample of SRs. We identified 682 SRs, suggesting that more than 8,000 SRs are being indexed in MEDLINE annually, corresponding to a 3-fold increase over the last decade. The majority of SRs addressed a therapeutic question and were conducted by authors based in China, the UK, or the US; they included a median of 15 studies involving 2,072 participants. Meta-analysis was performed in 63% of SRs, mostly using standard pairwise methods. Study risk of bias/quality assessment was performed in 70% of SRs but was rarely incorporated into the analysis (16%). Few SRs (7%) searched sources of unpublished data, and the risk of publication bias was considered in less than half of SRs. Reporting quality was highly variable; at least a third of SRs did not report use of a SR protocol, eligibility criteria relating to publication status, years of coverage of the search, a full Boolean search logic for at least one database, methods for data extraction, methods for study risk of bias assessment, a primary outcome, an abstract conclusion that incorporated study limitations, or the funding source of the SR. Cochrane SRs, which accounted for 15% of the sample, had more complete reporting than all other types of SRs. Reporting has generally improved since 2004, but remains suboptimal for many characteristics.
An increasing number of SRs are being published, and many are poorly conducted and reported. Strategies are needed to help reduce this avoidable waste in research.
系统评价(SRs)有助于决策者解读海量已发表的生物医学文献。然而,如果开展系统评价所采用的方法存在缺陷,且系统评价的报告不完整,那么其作用可能会很有限。据我们所知,自2004年以来,尚未有针对不同专业领域系统评价的患病率、关注点及报告完整性的横断面研究。因此,我们研究的目的是调查近期系统评价横断面的流行病学及报告特征。
我们检索了MEDLINE,以确定2014年2月期间索引的潜在合格系统评价。使用预先设定的纳入标准对文献进行筛选。由一名审阅者提取300篇系统评价随机样本的流行病学和报告特征,其中10%的样本进行重复提取。我们比较了Cochrane系统评价与非Cochrane系统评价的特征,以及2014年系统评价样本与2004年系统评价样本的特征。我们确定了682篇系统评价,这表明MEDLINE每年索引的系统评价超过8000篇,与过去十年相比增加了两倍。大多数系统评价解决的是治疗性问题,由中国、英国或美国的作者开展;它们纳入的研究中位数为15项,涉及2072名参与者。63%的系统评价进行了荟萃分析,大多采用标准的成对方法。70%的系统评价进行了研究偏倚风险/质量评估,但很少纳入分析(16%)。很少有系统评价(7%)检索未发表数据的来源,不到一半的系统评价考虑了发表偏倚风险。报告质量差异很大;至少三分之一的系统评价未报告是否使用系统评价方案、与发表状态相关的纳入标准、检索覆盖的年份、至少一个数据库的完整布尔检索逻辑、数据提取方法、研究偏倚风险评估方法、主要结局、纳入研究局限性的摘要结论或系统评价的资金来源。占样本15%的Cochrane系统评价的报告比所有其他类型的系统评价更完整。自2004年以来报告总体有所改善,但许多特征仍未达到最佳状态。
发表的系统评价数量在增加,许多系统评价的开展和报告情况不佳。需要采取策略来帮助减少这种可避免的研究浪费。